Integra LifeSciences (IART) Earnings Date, Estimates & Call Transcripts → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free IART Stock Alerts $29.38 +0.40 (+1.38%) (As of 04/23/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 6Before Market OpensConfirmedActual EPS (Feb. 28) $0.89 Missed By -$0.01 Consensus EPS (Feb. 28) $0.90 Read Call TranscriptListen to Call Get Integra LifeSciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for IART and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIART Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IART Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Integra LifeSciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.55$0.55$0.550.530 - 0.570Q2 20241$0.74$0.74$0.74 Q3 20241$0.87$0.87$0.87 Q4 20241$1.00$1.00$1.00 FY 20244$3.16$3.16$3.16 Q1 20251$0.74$0.74$0.74 Q2 20251$0.76$0.76$0.76 Q3 20251$0.98$0.98$0.98 Q4 20251$1.03$1.03$1.03 FY 20254$3.51$3.51$3.51 Q1 20261$0.72$0.72$0.72 IART Earnings Date and InformationIntegra LifeSciences last posted its earnings data on February 28th, 2024. The life sciences company reported $0.89 earnings per share for the quarter, missing the consensus estimate of $0.90 by $0.01. The business had revenue of $397 million for the quarter, compared to the consensus estimate of $399.30 million. Its revenue for the quarter was down .3% compared to the same quarter last year. Integra LifeSciences has generated $0.83 earnings per share over the last year ($0.83 diluted earnings per share) and currently has a price-to-earnings ratio of 35.4. Earnings for Integra LifeSciences are expected to grow by 13.17% in the coming year, from $3.19 to $3.61 per share. Integra LifeSciences has confirmed that its next quarterly earnings report will be published on Monday, May 6th, 2024. Integra LifeSciences will be holding an earnings conference call on Monday, May 6th at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Integra LifeSciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/6/2024Confirmed)------- 2/28/2024Q4 2023$0.90$0.89($0.01)$1.53$399.30 million$397.00 million 10/25/2023Q3 2023$0.78$0.76($0.02)$1.28$387.22 million$382.40 million 7/26/2023Q2 2023$0.57$0.71+$0.14$1.37$388.79 million$381.30 million 4/26/2023Q1 2023$0.74$0.74-$1.19$373.21 million$380.85 million 2/22/2023Q4 2022$0.93$0.94+$0.01$1.25$398.57 million$398.00 million 10/26/2022Q3 2022$0.72$0.86+$0.14$1.12$377.79 million$385.19 million Get the Latest News and Ratings for IART and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 7/27/2022Q2 2022$0.80$0.82+$0.02$1.10$394.54 million$397.82 million4/27/2022Q1 2022$0.68$0.74+$0.06$1.09$362.19 million$376.60 million 2/23/2022Q4 2021$0.83$0.84+$0.01$1.15$403.41 million$405.52 million 11/1/2021Q3 2021$0.72$0.86+$0.14$1.21$384.47 million$386.86 million 7/27/2021Q2 2021$0.66$0.79+$0.13$1.17$376.11 million$389.99 million 4/27/2021Q1 2021$0.57$0.69+$0.12$0.85$349.78 million$360.10 million Integra LifeSciences Earnings - Frequently Asked Questions When is Integra LifeSciences's earnings date? Integra LifeSciences has confirmed that its next quarterly earnings data will be published on Monday, May 6th, 2024. Learn more on IART's earnings history. Did Integra LifeSciences beat their earnings estimates last quarter? In the previous quarter, Integra LifeSciences (NASDAQ:IART) missed the analysts' consensus estimate of $0.90 by $0.01 with a reported earnings per share (EPS) of $0.89. Learn more on analysts' earnings estimate vs. IART's actual earnings. How can I listen to Integra LifeSciences's earnings conference call? The conference call for Integra LifeSciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Integra LifeSciences's conference call transcript? The conference call transcript for Integra LifeSciences's latest earnings report can be read online. Read Transcript How much revenue does Integra LifeSciences generate each year? Integra LifeSciences (NASDAQ:IART) has a recorded annual revenue of $1.54 billion. How much profit does Integra LifeSciences generate each year? Integra LifeSciences (NASDAQ:IART) has a recorded net income of $67.74 million. IART has generated $0.83 earnings per share over the last four quarters. What is Integra LifeSciences's price-to-earnings ratio? Integra LifeSciences (NASDAQ:IART) has a trailing price-to-earnings ratio of 35.40 and a forward price-to-earnings ratio of 9.21. The price/earnings-to-growth ratio is 0.86. What is Integra LifeSciences's EPS forecast for next year? Integra LifeSciences's earnings are expected to grow from $3.19 per share to $3.61 per share in the next year, which is a 13.17% increase. More Earnings Resources from MarketBeat Related Companies: ATEC Earnings ATRC Earnings GMED Earnings TFX Earnings PRCT Earnings ICUI Earnings NARI Earnings TNDM Earnings IRTC Earnings AXNX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:IART) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressFed launches fourth dollar overhaulStansberry ResearchThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
